IP Library Granted Patent US 12697348
Granted Patent B2
US 12697348 · App. 18/592,355 · Granted Aug 4, 2026

Compositions for promoting longevity and methods of using the same

Inventor: Paul Wagner (San Juan, PR)
Assignee: VITAL NUTRITION AND HEALTH INC
A61K31/7084A61K31/05A61K31/122A61K31/132A61K31/196A61K31/197A61K31/198A61K31/375A61K31/4188A61K31/519A61K31/7056A61K31/714A61K31/728A61K35/20A61K38/39
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12697348
App. No.
18/592,355
Granted
Aug 4, 2026
Kind
B2
Abstract

Disclosed herein are nutritional compositions aimed at promoting longevity and wellness. The compositions are formulated for oral intake and include a variety of nutrients and functional compounds such as proteins, creatine, antioxidants, vitamins, minerals, hyaluronic acid, biotin, CoQ10, spermidine, and one or more NAD + precursors. These components may serve to enhance muscle health, antioxidant function, skin, hair and joint health, cellular and cardiovascular health, thus contributing to the overall vitality and lifespan of an individual.

Claims (33)

1 . A composition comprising

(a) about 10 grams of collagen;

(b) about 5 grams of creatine;

(c) about 500 milligrams of trans-resveratrol;

(d) about 10 milligrams of spermidine and

ii. five or more of:

(a) about 500 milligrams of vitamin C;

(b) about 200 milligrams of CoQ10;

(c) about 1,000 micrograms of folate;

(d) about 100 micrograms of vitamin B12;

(e) about 500 milligrams of vitamin B5;

(f) about 500 milligrams of para-aminobenzoic acid (PABA);

(g) about 250 milligrams of one or more precursors of NAD + ;

(h) about 50 milligrams to about 300 milligrams of hyaluronic acid

(i) about 2,500 micrograms of biotin, and wherein the composition further comprises a source of dietary protein, wherein the source of dietary protein is an animal-based protein source, a plant-based protein source, or a combination thereof.

2 . The composition of claim 1 , wherein the precursor of NAD+ is/are selected from the group consisting of nicotinamide, NR, NMN, and niacin.

3 . The composition of claim 1 , wherein the vitamin B5 is present in the composition in the form of pantothenic acid, D-calcium pantothenate, pantethine, or a combination thereof.

4 . The composition of 1, wherein the composition further comprises a liquid solvent.

5 . The composition of claim 4 , wherein the liquid solvent comprises one or more of:

(a) water

(b) an animal-based milk; and

(c) a plant-based milk.

6 . The composition of claim 5 , wherein the plant-based milk is selected from the group consisting of soy milk, almond milk, oat milk, pea milk, rice milk, coconut milk, and macadamia nut milk.

7 . The composition of claim 1 , wherein the composition further comprises one or more sweetening agents selected from the group consisting of sucralose, stevia , aspartame, acesulfame potassium, xylitol, and erythritol.

8 . The composition of claim 1 , wherein the composition further comprises one or more flavoring agents selected from the group consisting of natural flavors, artificial flavors, cocoa powder, vanillin, citric acid, maltodextrin, a flavonoid, and a flavanol.

9 . The composition of claim 1 , wherein the composition comprises at least 30 grams of the source of dietary protein.

10 . The composition of claim 1 , wherein the composition comprises about 34 grams of the source of dietary protein.

11 . The composition of claim 1 , wherein the source of dietary protein is whey protein isolate.

12 . The composition of claim 1 , wherein the composition is formulated as a powdered composition.

13 . The composition of claim 4 , wherein the composition is formulated as a powdered composition.

14 . A method of promoting longevity to a human subject in need thereof, the method comprising: administering the composition of claim 13 to the human subject, wherein the composition is combined with about 8 fluid ounces to about 16 fluid ounces of a liquid solvent to form a liquid composition, wherein the administering is achieved via oral ingestion of the liquid composition.

15 . The method of claim 14 , wherein about 35 grams to about 40 grams of the composition is combined with the liquid solvent.

16 . The method of claim 15 , wherein the administering is once daily.